Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07817758

Preoperative Sarcopenia and Postoperative Outcomes in Older Patients With Gastrointestinal Cancer

This prospective cohort study aims to evaluate the association between preoperative sarcopenia and postoperative outcomes in patients aged 60 years or older undergoing elective surgery for gastrointestinal cancer. Sarcopenia will be assessed preoperatively using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria, including muscle strength, muscle mass, and physical performance, together with the Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls (SARC-F) questionnaire and calf circumference measurement. Participants will be followed for 90 days after surgery. Postoperative complications, length of hospital stay, and 30-day and 90-day mortality will be evaluated.

Recruiting

Interested in participating?

Request Info

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Van Education and Research Hospital

Van, 65300, Turkey (Türkiye)

Location status: Recruiting

Location contact

İbrahim Doğan, MD

CONTACT

[email protected]

+905313884966

About this study

Sarcopenia is characterized by reduced muscle strength, muscle mass, and physical performance and may be associated with unfavorable postoperative outcomes in older patients with cancer. This prospective, single-center observational cohort study will include patients aged 60 years or older who are scheduled to undergo elective surgery for gastrointestinal cancer at Van Training and Research Hospital.

Before surgery, demographic and clinical characteristics, including age, sex, and cancer diagnosis, will be recorded. Sarcopenia will be evaluated according to the EWGSOP2 criteria using measurements of muscle strength, muscle mass, and physical performance. The SARC-F questionnaire and calf circumference measurement will also be performed as part of the preoperative assessment.

Participants will receive standard surgical and perioperative care, and no treatment or intervention will be assigned by the study protocol. Patients will be observed for 90 days after surgery. Outcomes will include postoperative surgical complications, length of hospital stay, 30-day mortality, and 90-day mortality. Postoperative complications of interest will include anastomotic leakage, wound-related complications, oral intake intolerance, and delayed mobilization. The study will compare these outcomes between patients with and without preoperative sarcopenia and assess whether sarcopenia is independently associated with adverse postoperative outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 60 years or older
  • Diagnosis of gastrointestinal system cancer
  • Scheduled to undergo elective surgical treatment
  • Considered operable based on routine clinical evaluation
  • Ability to complete the preoperative sarcopenia assessments
  • Provision of written informed consent

Exclusion criteria

  • Age younger than 60 years
  • Undergoing emergency surgery
  • Inability to complete the required preoperative sarcopenia assessment

Treatment and study plan

Preoperative Sarcopenia Status

Other

Preoperative sarcopenia status will be determined according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria using assessments of muscle strength, muscle mass, and physical performance. The SARC-F questionnaire and calf circumference measurement will also be performed. No therapeutic intervention will be assigned by the study protocol.

Primary outcomes

  1. Incidence of postoperative complications

    Time frame: From the date of surgery through 90 days after surgery

    The number and percentage of participants who experience at least one postoperative complication, including anastomotic leakage, wound-related complications, oral intake intolerance, delayed mobilization, or another surgery-related complication. Complications will be identified through inpatient records and follow-up assessments.

Secondary outcomes

  1. Length of hospital stay

    Time frame: From the date of surgery through hospital discharge, an average of 7 days

    The duration of postoperative hospitalization, calculated in days from the date of surgery to the date of hospital discharge.

  2. 30-day all-cause mortality

    Time frame: Within 30 days after surgery

    The number and percentage of participants who die from any cause within 30 days after surgery.

  3. 90-day all-cause mortality

    Time frame: Within 90 days after surgery

    The number and percentage of participants who die from any cause within 90 days after surgery.

Study contacts

Contact information is provided by the study sponsor or research team.

İbrahim Doğan, MD

CONTACT

[email protected]

+905313884966

Sponsors and collaborators

Lead sponsor

Van Training and Research Hospital

Other Gov

Registry information

Official study title

The Effect of Preoperative Sarcopenia on Postoperative Prognosis in Older Patients With Gastrointestinal Cancer: A Prospective Cohort Study

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 14, 2026
Registry last updated
Sep 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.